Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients With Moderate Dementia of the Alzheimer's Type

NCT00334906 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00334906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00334906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients With Moderate Dementia of the Alzheimer's Type
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2005
Completion date
Not reported
Enrollment
75
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease